TD‐P‐21: THE EVOLUTION OF TECHNOLOGY IN DATA QUALITY PROGRAMS FOR ALZHEIMER'S DISEASE CLINICAL TRIALS: WHAT HAVE WE LEARNED AND WHERE ARE WE GOING?

Authors: Todd M. Solomon, H Todd Feaster, Sarah M. Karas, Macarena Garcia-Valdecasas, Jordan M. Barbone, Danielle T. DiGregorio, Dan DeBonis, David S. Miller

Published: 2019-10-18

DOI: 10.1016/j.jalz.2019.06.4332

Source: Full article


Abstract

No abstract found.